Results 161 to 170 of about 1,515,353 (171)

Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins

Atherosclerosis, 1978
C R Sirtori, Carlo Scolastico, Cesare R Sirtori   +2 more
exaly  

Hypolipidemic agents alter hepatic mitochondrial respiration

Comparative Biochemistry and Physiology C, Comparative Pharmacology and Toxicology, 1995
Michael K McIntosh
exaly  

Morphological changes in the liver of rats treated with a new hypolipidemic agent, S-8527

Atherosclerosis, 1973
Takeo Wada, Tetsuro Anzai
exaly  

Mechanisms of Low Density Lipoprotein Lowering by Hypolipidemic Agents

Annals of Medicine, 1991
Y A Kesaniemi, Y Antero Kesaniemi
exaly  

Synthesis and biological evaluation of ester prodrugs of benzafibrate as orally active hypolipidemic agents

European Journal of Medicinal Chemistry, 2012
Hemant V. Chavan, Rajendra J Sarangdhar, Babasaheb P Bandgar   +2 more
exaly  

Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidemic agent

Atherosclerosis, 1979
J Edelson, A Arnold
exaly  

Hypolipidemic activity of Anethum graveolens in rats

Phytotherapy Research, 2008
Valiolah Hajhashemi, Naser abbasi
exaly  

Hypolipidemic activity of in vitro inhibitors of hepatic and intestinal sn-glycerol-3-phosphate acyltransferase and phosphatidate phosphohydrolase

Atherosclerosis, 1977
S D Wyrick, Robert G Lamb, R G Lamb
exaly  

Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents

Bioorganic and Medicinal Chemistry Letters, 2005
exaly